Oculus Innovative Sciences Receives 'Strong Consensus' Rating for Use With Kinetic Concepts' Negative Pressure Wound Therapy With Instillation Apr 9, 2014
Oculus Innovative Sciences Announces Board of Directors Restructuring Following Ruthigen IPO Apr 2, 2014
Oculus Innovative Sciences Announces Appointment of Sharon Barbari to Its Board of Directors Mar 27, 2014
Oculus Innovative Sciences Announces Appointment of Russell Harrison to Board of Directors Feb 27, 2014
Oculus Innovative Sciences Receives Approval for Oral and Throat Infection Products in Mexico Feb 19, 2014
Oculus Innovative Sciences Reports Revenues of $3.3 Million for Third Quarter of Fiscal 2014 Feb 13, 2014
Oculus Innovative Sciences Announces Completion of Agreements Required for IPO by Company's Subsidiary, Ruthigen, Inc. Feb 6, 2014
Oculus Innovative Sciences Receives European CE Mark for Use of Microcyn(R) in the Topical Treatment of Mild to Moderate Acne Feb 4, 2014
Oculus Innovative Sciences Announces Fiscal Third Quarter 2014 Financial Results and Conference Call Jan 30, 2014
